120
Views
16
CrossRef citations to date
0
Altmetric
Letter

Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia

, , , , , & show all
Pages 665-668 | Received 16 Jul 2012, Accepted 06 Aug 2012, Published online: 12 Sep 2012

References

  • Bekassy AN, Hermans J, Gorin NC, . Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1996;17:801–808.
  • Simpson DR, Nevill TJ, Shepherd JD, . High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation. Bone Marrow Transplant 1998;22:259–264.
  • Lee KH, Lee JH, Choi SJ, . Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant 2003;32:835–842.
  • Ruiz-Arguelles GJ, Gomez-Almaguer D, Vela-Ojeda J, . Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning. Int J Hematol 2005;82:262–265.
  • Shimoni A, Rand A, Shem-Tov N, . Isolated extra-medullary relapse of acute leukemia after allogeneic stem-cell transplantation (SCT); different kinetics and better prognosis than systemic relapse. Biol Blood Marrow Transplant 2009;15(Suppl.):59–61.
  • Harris AC, Mageneau J, Braun T, . Extramedullary relapse in acute leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Biol Blood Marrow Transplant 2010;16:S177–S178.
  • Yoshihara S, Ikegame K, Kaida K, . Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome. Bone Marrow Transplant 2012;47:669–676.
  • Solh M, DeFor TE, Weisdorf DJ, . Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant 2012;18:106–112.
  • Cunningham I.Extramedullary sites of leukemia relapse after transplant. Leuk Lymphoma 2006;47:1754–1767.
  • Slovak ML, Kopecky KJ, Cassileth PA, . Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000;96: 4075–4083.
  • Gooley TA, Leisenring W, Crowley J, . Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 1999;18:695–706.
  • Gray RJ.A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1140–1154.
  • Cox DR.Regression models and life tables. J R Stat Soc 1972;B34:187–220.
  • Fine JP, Gray RJ.A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496–509.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.